Phyllis Kim, MD

Specialty:
Hematology and Medical Oncology

Background:
Dr. Phyllis Kim is a board-certified hematologist and oncologist who treats patients with benign and malignant hematologic conditions as well as solid tumors. Her areas of interest include malignant hematology, breast cancer, and GI malignancies. She is committed to delivering and expanding quality cancer care to our unique population at Olive View-UCLA. Other interests include medical education, physician wellness and burnout prevention, and quality improvement.

Dr. Kim received her undergraduate degree from the University of California at Berkeley majoring in Molecular and Cell Biology. She received her medical degree from the David Geffen School of Medicine at UCLA. She completed her Internal Medicine residency and chief residency at Olive View-UCLA Medical Center, then went on to complete fellowship training in Hematology and Medical Oncology at Harbor-UCLA Medical Center.

Research Interests:
Clinical Outcomes

Education:
M.D., David Geffen School of Medicine at UCLA, 2010
Internal Medicine Residency, Olive View-UCLA Medical Center, 2010-2013
Chief Resident Internal Medicine, Olive View-UCLA Medical Center, 2013-2014
Hematology and Medical Oncology Fellowship, Harbor-UCLA Medical Center, 2014-2017

Committees & Administrative Duties
Chair, Clinical Competency Committee, Fellowship in Hematology and Medical Oncology

Recent Publications & Projects:

Gupta R, Othman T, Uche A, Amanam I, Chen C, Celles L, Lane G, Mei M, Aldoss
I, Pullarkat V, Kim P, Yeh J. Characteristics and Trends of Adult Acute
Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital. Clin Lymphoma
Myeloma Leuk. 2020 Jun;20(6):e320-e327. doi: 10.1016/j.clml.2019.11.003. Epub
2020 Feb 28. PMID: 32199763.

Othman T, Hendizadeh MS, Vankina R, Park S, Kim P. Combined Cerebellar and
Spinal Cord Deficits Caused by an Underlying Gynecologic Malignancy. Case Rep
Oncol Med. 2020 Jan 8;2020:9021843. doi: 10.1155/2020/9021843. PMID: 31970005;
PMCID: PMC6973182.

Chuang J, Uche A, Gupta R, Margolin K, Kim P. Fulminant Disseminated
Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma. Case
Rep Oncol Med. 2019 Apr 9;2019:9246596. doi: 10.1155/2019/9246596. PMID:
31093395; PMCID: PMC6481122.

Moosavi L, Kim P, Uche A, Cobos E. A Synchronous Diagnosis of Metastatic Male
Breast Cancer and Prostate Cancer. J Investig Med High Impact Case Rep. 2019
Jan-Dec;7:2324709619847230. doi: 10.1177/2324709619847230. PMID: 31053047;
PMCID: PMC6505228.

Uche A, Vankina R, Gong J, Cho M, Yeh JJ, Kim P, Pan K. Capecitabine-induced
hypertriglyceridemia: a rare but clinically relevant treatment-related adverse
event. J Gastrointest Oncol. 2018 Dec;9(6):1213-1219. doi:
10.21037/jgo.2018.07.07. PMID: 30603144; PMCID: PMC6286928.

Interests:
Reading, audiobooks